Screening of RNA-seq Discoveries with nCounter Targeted Gene Expression Analysis

[Bruker]

Modern discovery research frequently begins with comprehensive techniques such as whole-transcriptome sequencing (RNA-seq) to reveal gene expression patterns, pathways, and biomarkers related to disease states or potential therapeutics. Broad RNA-seq can capture as many as 15,000-20,000 genes, which is coverage useful for discovery but large and unnecessary for routine monitoring assays. Once a promising subset of gene targets is identified, screening and monitoring expression of these genes through a narrower and more specific approach becomes essential. While qPCR was historically the gold-standard for quantitative monitoring, the ability to only measure 1-5 targets at a time is severely limiting. Instead, direct transcript detection and end-to-end analysis of up to 800 targets with the nCounter® Analysis System has gained prominence for both screening and analysis. This article highlights how the nCounter platform can facilitate a streamlined transition from broad discovery to focused translational research.

Advantages of nCounter for Translational Targeted Gene Expression
Selecting an effective platform for targeted gene expression analysis is vital for researchers aiming to translate broad genomic discoveries into actionable insights. The nCounter system offers several advantages over both qPCR and targeted RNA-seq, including reliability, precision, speed, and plex. These benefits together support a robust and high-throughput approach suitable for both foundational and translational research settings.

• Proven Correlation with Sequencing
  Multiple unbiased, peer-reviewed studies have illustrated a strong concordance between RNA-seq and nCounter data. One recent example demonstrated how nCounter and RNA-seq both detected the same molecular responses to viral infection in upper airway lung organoids [1]. Another study observed similar immune signatures when comparing nCounter to other platforms in immunotherapy-treated melanoma patients [2].
   
• Direct Transcript Detection
  Unlike approaches that utilize multiple enzymes and amplification processes, the nCounter platform uses a direct hybridization chemistry without enzyme-driven steps. The absence of reverse transcription and DNA amplification helps eliminate bias, reduces potential errors, and greatly simplifies the workflow. The use of direct hybridization probes results in both fast sample preparation and precise, reproducible data [3].
   
• Rapid Sample-to-Answer
  For translational research, turnaround time is frequently a critical factor. The nCounter system can deliver processed data in under 24 hours—a speed unmatchable by RNA-seq. The platform’s nSolver™ software and Advanced Analysis module also enable straightforward generation of volcano plots, heat maps, and pathway analyses, minimizing the need for specialized bioinformatics expertise.
   
• Robust 800-Plex Targeted Panels
  Supporting up to 800 genes in a single analysis, nCounter panels were developed from an extensive body of gene expression research. These curated panels cover core biological pathways, reducing the requirement for multiple assays or the creation of fully custom solutions. However, the nCounter platform is also compatible with custom-designed panels for unique research needs.

Performance Case Study: Robustness and Sensitivity for Translational Settings
Many detailed assessments of the performance of the nCounter platform have been published. In one key comprehensive study, researchers explored whether the nCounter system could meet the stringent requirements for high-throughput translational research [4]. The scope and findings of the evaluation included:

• Technical and Biological Replicates
  The nCounter platform was tested for reproducibility across both technical and biological replicates. The authors observed consistent performance and strong correlation coefficients, indicating reliable data generation even when tested on different days or by different operators.
   
• Performance with Low Sample Quality
  The study evaluated partially degraded and low-quality samples to simulate real-world conditions, such as samples from biopsies or archived fixed tissues. Despite variability in input RNA integrity, the direct hybridization chemistry of nCounter demonstrated sustained accuracy and sensitivity.
   
• Freeze-Thaw Stability and Assay Panel Durability
  Repeated freeze-thaw cycles were introduced to assess the stability of both reagents and samples. The study reported minimal impact on custom assay panel performance, suggesting that nCounter panels are robust enough to withstand common lab handling stresses.
   
• Lot-to-Lot Variability
  Consistency across different reagent and cartridge lots is critical for long-term research projects and clinical trials. The investigators found low lot-to-lot variability in nCounter reagents, reinforcing the platform’s reliability for studies extending over months or years.
   
• Linearity and Sensitivity
  The study also evaluated the dynamic range of nCounter assays. Results indicated strong linearity across a broad range of gene expression levels. This experiment also found reliable detection of low-abundance transcripts, which is an essential feature for rare-target analysis in heterogeneous tumor samples.

Following these tests, the authors concluded that the nCounter platform met or exceeded performance criteria suitable for analyzing translational and clinical trial samples. They further noted that minimal hands-on time, a straightforward workflow, and the direct digital readout provided advantages over alternative methods commonly used in multiplexed gene expression studies. As a result, they deemed nCounter to be a practical and reliable approach for generating high-sensitivity, reproducible data from complex or low-quality specimens. Read more about this case study.

Conclusion
Targeted gene expression analysis with the nCounter Analysis Platform offers a fast and reliable method for validating leads identified through whole transcriptome RNA-seq. By providing high concordance with sequencing, direct transcript detection, and a fast sample-to-data pipeline, nCounter technology aligns well with the needs of translational research seeking accurate results for a defined set of genes.

References

1. Rezapour, M., Walker, S. J., Ornelles, D. A., Niazi, M. K. K., McNutt, P. M., Atala, A., & Gurcan, M. N. (2024). A comparative analysis of RNA-Seq and NanoString technologies in deciphering viral infection response in upper airway lung organoids. Frontiers in Genetics, 15, 1327984. https://doi.org/10.3389/fgene.2024.1327984
2. Mao, Y., Gide, T. N., Adegoke, N. A., Quek, C., Maher, N., Potter, A., ... & Wilmott, J. S. (2023). Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach. Journal of translational medicine, 21(1), 257. https://doi.org/10.1186/s12967-023-04092-9
3. Northcott, P. A., Shih, D. J., Remke, M., Cho, Y. J., Kool, M., Hawkins, C., Eberhart, C. G., Dubuc, A., Guettouche, T., Cardentey, Y., Bouffet, E., Pomeroy, S. L., Marra, M., Malkin, D., Rutka, J. T., Korshunov, A., Pfister, S., & Taylor, M. D. (2012). Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta neuropathologica, 123(4), 615–626. https://doi.org/10.1007/s00401-011-0899-7
4. Veldman-Jones, M. H., Brant, R., Rooney, C., Geh, C., Emery, H., Harbron, C. G., ... & Marshall, G. (2015). Evaluating robustness and sensitivity of the NanoString technologies nCounter platform to enable multiplexed gene expression analysis of clinical samples. Cancer research, 75(13), 2587-2593. https://doi.org/10.1158/0008-5472.CAN-15-0262

[ribbitattorney]

That sounds really helpful, thanks for offering to share it. I’d definitely be interested in taking a look at the ZIP archive, especially to understand your workflow and how you generated the different submission files. It could be a great way to learn new approaches for improving model performance and ensemble strategies. Appreciate you being open about your process and sharing resources with the community.

top games

[verity]

The integration of RNA-seq with nCounter analysis highlights the importance of verification in genomic research. Accurate validation is essential for meaningful biological insights.

[pekgio]

The comparison with both qPCR and RNA-seq provides useful context for researchers evaluating platforms for scalable, reproducible gene expression analysis. Thanks for sharing these insights and the supporting literature.

Dinosaur Game